Navigating the Future: Real-Time PCR, Digital PCR And End-Point PCR Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Real-Time PCR, Digital PCR And End-Point PCR Market Size Growth Forecast: What to Expect by 2025?
Over the years, the market size for real-time pcr, digital pcr and end-point pcr has shown significant growth. An increase from $38.37 billion in 2024 to $41.88 billion in 2025 is anticipated, with a compound annual growth rate (CAGR) of 9.2%. The boost in growth during the historic period is credited to the standardization of PCR protocols, its role in personalized medicine, its contribution to drug discovery and development, as well as its adoption in forensic and paternity testing.

How Will the Real-Time PCR, Digital PCR And End-Point PCR Market Size Evolve and Grow by 2029?
Expansion in the real-time pcr, digital pcr, and end-point pcr market is anticipated in the coming years, with projections suggesting a growth to $60.91 billion in 2029 at a CAGR of 9.8%. Various factors such as the advancement of molecular diagnostics, increased testing for infectious diseases, growing demand for genetic testing, infiltration of the market in research and forensics along with prompt point-of-care PCR solutions are driving this growth. Furthermore, future trends like the advent of digital assays, progression in multiplex PCR, the shift towards digital PCR technology, the introduction of automated and high-throughput systems, and the miniaturization of PCR platforms would continue to influence the market during the forecast period.

View the full report here:
https://www.thebusinessresearchcompany.com/report/real-time-pcr-digital-pcr-and-end-point-pcr-global-market-report

What Drivers Are Propelling the Growth of Real-Time PCR, Digital PCR And End-Point PCR Market Forward?
The rise in infectious disease occurrences is anticipated to fuel the expansion of the real-time PCR, digital PCR, and end-point PCR markets. The term infectious diseases is used to describe ailments resulting from the intrusion and proliferation of harmful microorganisms like bacteria, viruses, fungi, and parasites. Infectious diseases utilises real-time PCR, digital PCR, and end-point PCR for the quantification of specific pathogens or their genetic material, tracking of disease progress, as well as quick diagnosis of infections like HIV, hepatitis, respiratory viruses, and tuberculosis. For example, in July 2023, the UNAIDS, a Swiss UN initiative addressing the worldwide HIV/AIDS epidemic stated the global populace living with HIV had risen by 3.17% to 39 million in 2022, up from 37.7 million in 2020. Also, it was reported that there were around 1.3 million new HIV infections in 2022. Furthermore, the Centers for Disease Control and Prevention, a US public health organization indicated in March 2023, that the United States had reported 8,300 tuberculosis (TB) cases in 2022, an increase from 7,874 cases in 2021. Hence, the rise in infectious disease occurrences is anticipated to stimulate the growth of the cephalosporin market. Real-Time PCR, Digital PCR And End-Point PCR Market Growth Strategy: The Boost in PCR Technologies Following An Increase In Chronic Diseases

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp

Which Emerging Trends Are Transforming the Real-Time PCR, Digital PCR And End-Point PCR Market in 2025?
Leading firms in the real-time PCR, digital PCR, and end-point PCR markets are harnessing cutting-edge technologies like digital polymerase chain reaction (dPCR) to gain deeper insights into diseases such as cancer, genetic disorders, and infections. The dPCR technology is an advanced version of the traditional polymerase chain reaction (PCR) methods and can directly amplify and count nucleic acid strands like DNA, cDNA, or RNA. For example, in August 2022, Roche Diagnostics, a US pharmaceutical and medical devices producer, rolled out its next-generation digital PCR system, Digital LightCycler, designed to detect and manage various genetic and chronic diseases at an early stage. This system automates workflow, handles data, and obviates the necessity for external processors, calculations, and software. It offers a high degree of precision and sensitivity, thanks to the integration of three nano well plate configurations, six sophisticated optical channels, and 5x concentrated DNA and RNA master mixes. Roche's diagnostic platform portfolio is enriched by the addition of the Digital LightCycler System, which promises improved technology, clinical usage, adaptability, and automated workflow.

What Are the Key Segments in the Real-Time PCR, Digital PCR And End-Point PCR Market?
The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented -

1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations

Subsegments:
1) By Instruments: Real-Time PCR Systems, Digital PCR Systems, End-Point PCR Systems
2) By Consumables And Reagents: PCR Plates And Tubes, Primers And Probes, PCR Master Mix, DNA Polymerases And Nucleotides
3) By Software And Services: Analysis Software, Data Management Software, Calibration And Maintenance Services, Training And Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13296&type=smp

Who Are the Key Players Shaping the Real-Time PCR, Digital PCR And End-Point PCR Market's Competitive Landscape?
Major companies operating in the real-time PCR, digital PCR and end-point PCR market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton inson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG, Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

What Geographic Markets Are Powering Growth in the Real-Time PCR, Digital PCR And End-Point PCR Market?
North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time PCR, digital PCR and end-point PCR market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13296

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.